ArticleBMC cancer2012

Development of a gene therapy strategy to target hepatocellular carcinoma based inhibition of protein phosphatase 2A using the α-fetoprotein promoter enhancer and pgk promoter: an in vitro and in vivo study.

Wei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.